Home | DAIC

Magmaris Scaffold Performs Well in Real World Settings Even in More Complex Patient Groups

BIOSOLVE-IV Full-Cohort Two-Year Data Confirm Excellent Safety and Efficacy Profile of Magmaris Resorbable Magnesium Scaffold

September 27, 2022 — BIOTRONIK announced the presentation of new full-cohort 2-year BIOSOLVE-IV data. In a poster ...

September 27, 2022

a late breaking abstract describing dose response data from its positive Phase 2 clinical study of istaroxime in early cardiogenic shock (SEISMiC) will be presented on October 2 at the Heart Failure Society of America Annual Scientific Meeting in Washington, DC.

News | Cardiogenic Shock

Windtree Therapeutics Announces Istaroxime Late Breaker Abstract from its Positive Phase 2 Study in Early Cardiogenic Shock (SEISMiC) to be Presented at Heart Failure Society of America

September 27, 2022 — Windtree Therapeutics, Inc., a biotechnology company focused on advancing multiple late-stage ...

September 27, 2022

Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards' breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve.

News | Heart Valve Technology

Edwards Launches Sapien 3 Ultra Resilia Valve Following FDA Approval

September 26, 2022 — Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates ...

September 26, 2022

Sponsored Content

Feature | Thrombectomy Devices

Redefining PE and VTE Intervention

Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...

June 01, 2026

UC San Diego researchers have created the first diagnostic tool able differentiate between two similar pediatric inflammatory conditions, using a novel artificial intelligence-guided algorithm

News | Coronavirus (COVID-19)

How to Tell the Difference between Kawasaki Disease and MIS-C

September 26, 2022 — Kawasaki disease (KD) is the leading cause of acquired heart disease in children in developed ...

September 26, 2022

Evolut FX TAVR System Adds Innovative Features to Enhance Ease-of-Use and Predictable Valve Deployment

News | Structural Heart

Medtronic Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis

September 26, 2022 — Medtronic plc, a global leader in medical technology, announced U.S. Food and Drug Administration ...

September 26, 2022

Study of the Paradise Ultrasound Renal Denervation System Shows Significant Reduction in Blood Pressure in Patients with Uncontrolled Hypertension

News | Hypertension

ReCor Medical Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting

September 26, 2022 — ReCor Medical, Inc., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced the ...

September 26, 2022

Sponsored Content

Feature | Cardiac Imaging

Providing Clarity into CAD

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

March 13, 2026

Avicenna.AI are a medical imaging AI developer, optimizing radiologists’ manual tasks and identifying acute abnormalities. This partnership involves their stroke product suite, which enables automatic identification and triage for acute stroke.

News | Artificial Intelligence

Avicenna.AI Partners With deepc to Revolutionize Stroke Patient Care

September 22, 2022 — Medical imaging specialist Avicenna.AI announced a groundbreaking partnership with the MedTech ...

September 22, 2022

Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella-supported patients treated at 109 hospitals in Japan shows a 30-day survival rate of 77% for patients with cardiogenic shock due to myocarditis.

News | Cardiogenic Shock

Multi-Center, Multi-Society Study of Impella-supported Patients with Cardiogenic Shock due to Myocarditis in Japan Achieves 30-day Survival of 77%

September 22, 2022 — Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella ...

September 22, 2022

David J. Cohen, MD, MSc, St. Francis Hospital and CRF, presented Jennifer A. Rymer, MD, Duke University Medical Center with the TCT 2022 Thomas J. Linnemeier Young Investigator Award, along with co-presenter Gary S. Mintz of the Cardiovascular Research Foundation (CRF) on Sept 19 in Boston, MA.

News | TCT

TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award

September 22, 2022 — The recipient of the TCT 2022 Thomas J. Linnemeier “Spirit of Interventional Cardiology” Young ...

September 22, 2022

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

News | Stents Bifurcation

Medtronic Receives FDA Indication for Bifurcation Percutaneous Coronary Intervention with a Drug-eluting Stent

September 21, 2022 — Medtronic announced today that it has received Food and Drug Administration (FDA) approval for the ...

September 21, 2022

EMPOWER CAD is the First Prospective, Female-Only Study of Coronary Interventions

News | Womens Cardiovascular Health

Shockwave Medical Initiates All-Female Coronary IVL Study

September 21, 2022 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat ...

September 21, 2022

Over the 10-year span, median cardiology compensation – regardless of ownership model – increased (Figure 1). From 2011 to 2021, private cardiology compensation expanded by 32% to a median of $604,652 per FTE, and integrated cardiology income increased by 13% to $621,596 per FTE.

News | Cardiovascular Business

Cardiology Compensation and New Patient Visits Rebound, Survey Finds

September 21, 2022 — MedAxiom, the premier source for cardiovascular organizational performance solutions, has released ...

September 21, 2022

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

Statistically significant mean reductions of 10.3 mmHg in 24-hour ambulatory systolic blood pressure and 11.7 mmHg in ambulatory pulse pressure after 6 months of therapy in control patients who crossed over to BackBeat CNT following completion of the randomized portion of the MODERATO II study

News | Hypertension

Orchestra BioMed Announces Presentation of Positive Long-Term Clinical Results from MODERATO II Control Patients Crossover Extension Study of BackBeat CNT at TCT 2022

September 20, 2022 — Orchestra BioMed, Inc., a biomedical innovation company accelerating high-impact technologies to ...

September 20, 2022

The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population

News | Pediatric Cardiology

Medtronic Receives FDA Clearance for Expanded Indication of LINQ II Insertable Cardiac Monitor For Use in Pediatric Patients Ages 2 and Older

September 20, 2022 — Medtronic, a global leader in healthcare technology, today announced the LINQ II Insertable Cardiac ...

September 20, 2022

Results of the CLASP IID Trial Presented at TCT and published simultaneously in JACC: Cardiovascular Interventions

News | Structural Heart

Novel TEER Repair Device Meets Primary Endpoint in Treating Degenerative Mitral Regurgitation in Patients Not Eligible for Surgery

September 20, 2022 — Results of the first randomized controlled trial to directly compare two contemporary transcatheter ...

September 20, 2022